The 20 Best Thyroid Cancer Doctors near Baltimore, MD

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Kashif Munir is an Endocrinologist in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Douglas Turner is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Turner is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Hyperparathyroidism, Follicular Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Shadi Barakat is an Endocrinologist in Baltimore, Maryland. Dr. Barakat has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Type 2 Diabetes (T2D), Toxic Nodular Goiter, Thyroid Cancer, and Thyroid Storm.

Jon Russell is an Otolaryngologist in Columbia, Maryland. Dr. Russell is rated as an Elite provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Thyroid Nodule, Thyroidectomy, and Parathyroidectomy.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy.

Aarti Mathur, M.D., FACS, is an experienced, fellowship-trained endocrine surgeon in the Johns Hopkins Division of Surgical Oncology and an associate professor of surgery at the Johns Hopkins University School of Medicine. Dr. Mathur sees patients at The Johns Hopkins Hospital in Baltimore and at Sibley Memorial Hospital in Washington, D.C. Dr. Mathur earned her medical degree at the University of Texas. She completed a general surgery residency at MedStar Georgetown University Hospital, followed by fellowships at the National Cancer Institute, where she studied immunotherapy and surgical oncology for several years, performed endocrine surgery research and cared for patients with advanced oncologic diseases. Dr. Mathur also completed a fellowship in endocrine surgery at the Johns Hopkins University School of Medicine. Dr. Mathur’s practice exclusively focuses on surgical management of benign and malignant diseases of the thyroid, parathyroid, adrenal glands and cervical lymph nodes. Her expertise includes thyroid surgery for nodules, goiters, Graves disease, thyroid cancer and minimally invasive parathyroidectomy, surgery for persistent or recurrent hyperparathyroidism and laparoscopic adrenalectomy. She believes in providing state of the art, patient-centered multi-disciplinary care for complex endocrine surgical issues. Dr. Mathur serves on multiple committees of major national societies including the American Association of Endocrine Surgeons, the American Thyroid Association, and the American College of Surgeons. As a surgeon-scientist, Dr. Mathur directs a research group, funded by the National Institutes of Health, that studies voice and swallowing outcomes after thyroidectomy in older adults. Her research also focuses on understanding the link between hyperparathyroidism and other health conditions including cognitive impairment, cardiovascular disease and post-transplant outcomes. Dr. Mathur has numerous prestigious national research awards and grants, and she has published over 50 peer reviewed articles, reviews and book chapters. She is frequently invited to present her research at national and international meetings. Dr. Mathur is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy.

Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Thyroidectomy, and Parathyroidectomy.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. Her top areas of expertise are Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Michael Xing is an Endocrinologist in Baltimore, Maryland. Dr. Xing is rated as an Advanced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Thyroid Nodule, Follicular Thyroid Cancer, Thyroid Cancer, and Medullary Thyroid Carcinoma.

Norman G. Nicolson, M.D., M.H.S., is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine and a surgical oncologist within the Division of HPB & Gastrointestinal Surgical Oncology. Dr. Nicolson completed his complex general surgical oncology clinical fellowship training and an NIH-funded T32 research fellowship at Johns Hopkins prior to joining the surgical faculty. Prior to this, he completed his undergraduate work at Williams College and medical degree at Northwestern University, followed by internship and residency in general surgery at Yale New Haven Hospital with a Masters in Health Sciences and research fellowship at Yale University. Dr. Nicolson specializes in treating patients with gastric cancer, peritoneal surface malignancy, appendiceal neoplasms, retroperitoneal sarcoma, gastrointestinal neuroendocrine and stromal tumors, and complex or recurrent tumors of the GI tract. He is trained in both minimally invasive and traditional open approaches to treating these cancers, utilizing laparoscopic or robotic approaches when appropriate. He emphasizes the importance of multi-disciplinary care and patient-centered decision-making, working closely with colleagues in medical and radiation oncology, gastroenterology, and radiology to provide comprehensive personalized cancer care appropriate to each individual. Dr. Nicolson's translational research focuses on computational and bioinformatics approaches to high-dimensional sequencing data from human biospecimens to better understand tumor cell biomarker heterogeneity and the importance of the tumor-draining lymph node in tumor-immune cell interactions in gastrointestinal tumors. He is a member of several academic and clinical professional societies, including the American College of Surgeons, the Association for Academic Surgery, the American Society for Clinical Oncology, the American Association for Cancer Research, and the Society of Surgical Oncology. Dr. Nicolson is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Follicular Thyroid Cancer, Pancreaticoduodenectomy, and Thyroidectomy.

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

"Pediatric otolaryngologist Jonathan Walsh specializes in head and neck masses, thyroid disorders, vascular malformations, tracheostomy, tracheal stenosis, aerodigestive disorders, chronic ear disease (ear infections), sinus disease (sinusitis), hearing loss, ankyloglossia (tongue-tie), sleep apnea and laryngeal cleft, as well as the full spectrum of pediatric head and neck disorders. He offers minimally invasive endoscopic ear surgery and minimally invasive surgeries of the airway, ear and sinus. Dr. Walsh earned a medical degree from Virginia Commonwealth University School of Medicine and completed residency training in otolaryngology at University of Rochester Medical Center. He served two years of active-duty service as a major in the U.S. Army at Fort Gordon in Georgia, after which he completed fellowship training in pediatric otolaryngology at the University of North Carolina. His research interests are in novel imaging technology applications for head and neck disorders; outcomes and health care disparities; ankyloglossia and lip tie; head and neck masses; and airway imaging and modeling. Dr. Walsh is director of the Johns Hopkins pediatric aerodigestive team and surgical director of the pediatric thyroid team. Additionally, he is an active participant in the vascular anomalies team, fetal therapy multidisciplinary team and pediatric sarcoma tumor board. Dr. Walsh is also the residency program director for the Department of Otolaryngology-Head and Neck Surgery. Videos Meet Our Expert - Dr. Jonathan Walsh Recent News Articles and Media Coverage More babies getting their tongues clipped to help breastfeed. But is it necessary? Today Show (7/11/2019) To Improve Breastfeeding, Babies Get Their Tongues Clipped, Is it Necessary? Podast WYPR (3/19/2019) Snipping an infant's ""tongue tie"" can improve breastfeeding. But is surgery being overused? The Inquirer (3/12/2019) Why so Many Babies are Getting Their Tongues Clipped Atlantic, (3/12/2019) The Tongue Tie Conundrum, Slate (2/6/2018) An Incisionless Approach to Ear Drum Repair, Johns Hopkins Medicine (10/2/2018)". Dr. Walsh is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Tongue Tie, Infant Hearing Loss, Laryngomalacia, Adenoidectomy, and Endoscopy.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Experienced provider by MediFind in the treatment of Thyroid Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.